Covestor’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
Covestor's MYGN Position: Q3 2026 in Review
Covestor reduced its Myriad Genetics (MYGN) stake by 40% in Q3 2026, cutting 34 shares and leaving 51 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2661.
Covestor first reported a position in MYGN in Q4 2021 and has held it in 20 quarters since. The position peaked at $1K in Q1 2025. 176 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.
- Covestor held 51 shares of Myriad Genetics worth $0 as of Q3 2026.
- Covestor sold 34 Myriad Genetics shares in Q3 2026.
- Myriad Genetics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2661 holding.
- Covestor first reported a position in Myriad Genetics in Q4 2021 and has held it in 20 quarters since.
- Covestor's Myriad Genetics position peaked at $1K in Q1 2025.
- 176 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.